LITS
Lite Strategy, Inc.
NASDAQ: LITS · HEALTHCARE · BIOTECHNOLOGY
$1.15
+0.00% today
Updated 2026-04-30
Market cap
$42.54M
P/E ratio
—
P/S ratio
0.31x
EPS (TTM)
$-1.82
Dividend yield
—
52W range
$1 – $8
Volume
0.3M
WallStSmart proprietary scores
41
out of 100
Grade: D
Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D4.7
Valuation
C—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-1.93M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $40.70M | $48.82M | $65.30M | $0.00 | $0.00 |
| Net income | $-54.45M | $-31.84M | $17.78M | $-15.95M | $-30.80M |
| EPS | — | — | — | — | $-1.82 |
| Free cash flow | $-49.23M | $-52.52M | $-50.48M | $-20.84M | $-1.93M |
| Profit margin | -133.80% | -65.22% | 27.23% | — | — |
Peer comparison
Smart narrative
Lite Strategy, Inc. trades at $1.15. Our Smart Value Score of 41/100 indicates the stock is fair.
Frequently asked questions
What is Lite Strategy, Inc.'s stock price?
Lite Strategy, Inc. (LITS) trades at $1.15.
Is Lite Strategy, Inc. overvalued?
Smart Value Score 41/100 (Grade D, Sell).
What is the price target of Lite Strategy, Inc. (LITS)?
The analyst target price is $—, representing NaN% downside from the current price of $1.15.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.31x
ROE-76.40%
Beta0.10
50D MA$1.15
200D MA$2.31
Shares out0.04B
Float0.03B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—